PDE4A and chronic obstructive pulmonary disease: PDE3 and PDE4 are promising targets for COPD, as both are expressed in airway and inflammatory cells, and regulate the second messenger molecules cyclic adenosine monophosphate and cyclic guanosine monophosphate.